Clinical trials for Osteosarcoma
34 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT07477457A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With OsteosarcomaMemorial Sloan Kettering Cancer Center · PI: Damon Reed, MD
- RECRUITINGPhase 1NCT06492954Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed OsteosarcomaEmory University · PI: Thomas Cash, MD, MSc
- RECRUITINGN/ANCT07129226Musculoskeletal Cancers Remote Monitoring and CareCase Comprehensive Cancer Center
- RECRUITINGPhase 1NCT07144254Tegavivint With Gemcitabine in Patients With Relapsed or Refractory OsteosarcomaEmory University · PI: Thomas Cash, MD, MSc
- RECRUITINGPhase 1NCT07227571Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe TrialFred Hutchinson Cancer Center · PI: Michelle Choe, MD
- RECRUITINGPhase 1NCT07052383Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue SarcomasTcelltech Inc. · PI: Gangxiong Huang, MD
- RECRUITINGPHASE1, PHASE2NCT06892678DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or OsteosarcomaMontefiore Medical Center · PI: Alice Lee, MD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05660408RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid TumorsUniversity of Florida · PI: John Ligon, MD
- RECRUITINGPhase 2NCT06650514A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade OsteosarcomaVall d'Hebron Institute of Oncology
- RECRUITINGPhase 2NCT06714383Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of OsteosarcomaPeking University People's Hospital
- ACTIVE NOT RECRUITINGNCT06850506Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis AssessmentPeking University People's Hospital
- RECRUITINGPhase 1NCT06235125Safety and Feasibility of Intraoperative Visualization With Cytalux in ChildrenAnn & Robert H Lurie Children's Hospital of Chicago · PI: Timothy Lautz, MD
- RECRUITINGNCT06384404Upfront Surgical Resection for OsteosarcomaMontefiore Medical Center · PI: Alice Lee, M.D.
- RECRUITINGNCT06064682An Organoid-based Functional Precision Medicine Trial in OsteosarcomaJonsson Comprehensive Cancer Center · PI: Alice Soragni, PhD
- RECRUITINGNCT06324916Donor Site Morbidity After Free Vascularized Fibular GraftAssiut University
- RECRUITINGPhase 2NCT05926492A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in OsteosarcomaSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGPHASE1, PHASE2NCT06778603B7-H3 NIR Imaging for Osteosarcoma SurgeryPeking University People's Hospital
- RECRUITINGNCT05942456Soluble B7-H3 as a Biomarker for OsteosarcomaPeking University People's Hospital
- RECRUITINGPhase 2NCT06114225Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical TrialRuijin Hospital · PI: Weibin Zhang, PhD, MD
- RECRUITINGPHASE1, PHASE2NCT05588648Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive OsteosarcomaMedPacto, Inc.
- RECRUITINGPhase 3NCT05328258Use of GnRHa During Chemotherapy for Fertility ProtectionKenny Rodriguez-Wallberg
- ACTIVE NOT RECRUITINGPhase 1NCT05312411A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic SarcomaSeattle Children's Hospital · PI: Catherine Albert, MD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT05395741Regorafenib in Patients With Refractory Primary Bone TumorsInstitute of Mother and Child, Warsaw, Poland · PI: Anna Raciborska, Prof.
- RECRUITINGPhase 2NCT05182164Combination of Pembrolizumab and Cabozantinib in Patients With Advanced SarcomasInstitut Bergonié
- ACTIVE NOT RECRUITINGPhase 2NCT04803877SARC038: Phase 2 Study of Regorafenib and Nivolumab in OsteosarcomaSarcoma Alliance for Research through Collaboration
- RECRUITINGPhase 2NCT04758000Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of RelapseIstituto Ortopedico Rizzoli · PI: Alessandra Longhi, MD
- ACTIVE NOT RECRUITINGEarly Phase 1NCT04634227Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)University of Iowa · PI: John Rieth, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03778996SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for SarcomaSarcoma Oncology Research Center, LLC · PI: Sant P Chawla, MD
- RECRUITINGNCT04132895ICONIC: Improving Outcomes Through Collaboration in OsteosarComaUniversity College, London · PI: Sandra Strauss, MD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT03598595Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory OsteosarcomaM.D. Anderson Cancer Center · PI: John A Livingston
- RECRUITINGNCT03458520Pediatric PET/MR Image RegistryStanford University · PI: Heike Daldrup-Link, MD
- ACTIVE NOT RECRUITINGPhase 2NCT02502786Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent OsteosarcomaMemorial Sloan Kettering Cancer Center · PI: Filemon Dela Cruz, MD
- ACTIVE NOT RECRUITINGPhase 2NCT02243605Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing SarcomaNational Cancer Institute (NCI) · PI: Antoine Italiano
- RECRUITINGNCT00411060Clinical Orthopaedic Data Bank (Acute and Chronic)University of Florida · PI: Parker Gibbs, MD